Umass Memorial Medical Center, INC.

Umass Memorial Medical Center, INC. was paid $491.01M by Medicaid between Jan 2018 and Dec 2024, across 1162 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 13% of everything it billed.

Compared with peers

Next to other General Acute Care Hospital providers in Massachusetts

Rank by total paid#2 of 66

Median peer was paid$29.11M

This provider vs. median17×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	1,291,823	$66.85M
2019	1,388,831	$65.51M
2020	1,120,175	$54.08M
2021	1,481,001	$70.10M
2022	1,554,531	$81.17M
2023	1,550,955	$81.28M
2024incomplete	1,337,865	$72.02M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	13%	459,556	387,479	$61.67M
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	6.0%	206,128	173,700	$29.23M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	5.3%	139,913	126,219	$25.99M
96361	Intravenous infusion, hydration; each additional hour	4.7%	62,693	52,867	$22.97M
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	3.8%	145,633	125,633	$18.47M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	3.0%	93,042	86,497	$14.84M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	3.0%	91,168	84,143	$14.71M
A0429	Emergency ambulance ride, basic life supportAmbulance service, basic life support, emergency transport (bls-emergency)	2.6%	59,418	49,097	$12.84M
G0463	Hospital outpatient clinic visit for assessment and management of a patient	2.1%	385,542	279,658	$10.44M
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	1.9%	67,301	61,637	$9.49M
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	1.8%	27,304	17,801	$8.62M
J2350	Injection, ocrelizumab, 1 mg	1.7%	1,025	956	$8.48M

1150 more codes

A0427	Emergency ambulance ride, advanced life support	1.5%	34,956	$7.29M
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	1.3%	54,300	$6.54M
J1745	Injection, infliximab, excludes biosimilar, 10 mg	1.2%	4,374	$6.10M
96415		1.1%	10,630	$5.60M
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	1.0%	78,308	$5.13M
96110	Developmental screening, with scoring and documentation, per standardized instrument	1.0%	29,086	$4.94M
74177	Computed tomography, abdomen and pelvis; with contrast material	<1%	32,691	$4.59M
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	7,013	$4.56M
G0378	Hospital observation service, per hour	<1%	36,263	$4.29M
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	26,056	$4.28M
99282	Emergency department visit for the evaluation and management, low to moderate severity	<1%	25,295	$3.91M
S9485	Crisis intervention mental health services, per diem	<1%	6,871	$3.59M
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	4,726	$3.55M
77386		<1%	15,645	$3.55M
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	11,181	$3.30M
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	26,880	$3.21M
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	4,785	$3.12M
70450	Computed tomography, head or brain; without contrast material	<1%	23,396	$2.96M
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	16,962	$2.81M
20610		<1%	17,169	$2.48M
99204	Doctor's office visit, new patient (more involved)	<1%	18,626	$2.47M
92014	Ophthalmological services: medical examination and evaluation, comprehensive, established patient	<1%	32,644	$2.47M
J9271	Injection, pembrolizumab, 1 mg	<1%	569	$2.36M
43235		<1%	2,973	$2.01M
76770		<1%	12,251	$1.94M
J2357	Injection, omalizumab, 5 mg	<1%	2,342	$1.88M
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	14,312	$1.87M
77412		<1%	12,356	$1.84M
J0585	Injection, onabotulinumtoxina, 1 unit	<1%	4,133	$1.83M
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	18,757	$1.82M
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	15,565	$1.74M
36430		<1%	5,530	$1.64M
J9312	Injection, rituximab, 10 mg	<1%	834	$1.60M
76830	Ultrasound, transvaginal	<1%	16,023	$1.58M
77067	Screening mammography, bilateral, including computer-aided detection	<1%	32,814	$1.53M
92587		<1%	12,308	$1.49M
97803		<1%	19,349	$1.45M
52000		<1%	2,474	$1.42M
J7298	Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg	<1%	1,500	$1.40M
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	314,861	$1.38M
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	15,391	$1.38M
62323		<1%	2,830	$1.32M
76819	Fetal biophysical profile; without non-stress testing	<1%	17,817	$1.30M
99391	Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year)	<1%	12,530	$1.29M
31575		<1%	7,143	$1.28M
93971		<1%	8,270	$1.27M
96402		<1%	2,091	$1.27M
J2505	Injection, pegfilgrastim, 6 mg	<1%	905	$1.25M
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	5,663	$1.22M
20611		<1%	3,936	$1.21M
42820	Tonsillectomy and adenoidectomy; younger than age 12	<1%	654	$1.20M
99203	Doctor's office visit, new patient (routine)	<1%	8,479	$1.19M
59025	Fetal non-stress test	<1%	4,208	$1.17M
64493		<1%	2,026	$1.16M
99392	Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years)	<1%	12,488	$1.16M
44970		<1%	356	$1.16M
67028	Intravitreal injection of a pharmacologic agent	<1%	7,003	$1.15M
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	34,831	$1.14M
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	22,740	$1.12M
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	1,758	$1.09M
69436	Tympanostomy (requiring insertion of ventilating tube), general anesthesia	<1%	990	$1.08M
70496		<1%	5,374	$1.05M
77063	Screening digital breast tomosynthesis, bilateral	<1%	17,902	$1.04M
11102		<1%	2,756	$1.04M
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	58,713	$1.03M
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	2,759	$1.03M
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	<1%	16,734	$1.02M
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	38,633	$1.01M
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	38,624	$1.01M
76642		<1%	11,238	$1.00M
J7307	Etonogestrel (contraceptive) implant system, including implant and supplies	<1%	877	$997K
71046	Radiologic examination, chest; 2 views	<1%	75,597	$984K
99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	<1%	11,228	$981K
93975		<1%	10,812	$978K
95886		<1%	4,882	$951K
99395	Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years	<1%	11,292	$913K
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	3,923	$903K
A0425	Ground mileage, per statute mile	<1%	95,320	$894K
99215	Doctor's office visit, returning patient (complex)	<1%	6,294	$882K
96367		<1%	4,895	$859K
66984	Extracapsular cataract removal with insertion of intraocular lens prosthesis	<1%	1,207	$846K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	16,059	$843K
76811	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed	<1%	6,300	$839K
93308		<1%	4,326	$818K
64483		<1%	1,638	$808K
99394	Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years)	<1%	8,929	$793K
G0121	Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk	<1%	1,522	$790K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	9,938	$781K
Q5119	Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg	<1%	619	$769K
81420	Fetal chromosomal aneuploidy genomic sequence analysis panel	<1%	1,549	$759K
99396	Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years	<1%	9,845	$753K
76536		<1%	7,381	$748K
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	44,891	$748K
V5261	Hearing aid, digital, binaural, bte	<1%	795	$731K
29075		<1%	3,293	$723K
97802		<1%	9,523	$721K
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	5,191	$705K
J1459	Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg	<1%	1,405	$702K
52356		<1%	264	$702K
J3380	Injection, vedolizumab, intravenous, 1 mg	<1%	175	$702K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	4,089	$660K
ATP14		<1%	73,415	$635K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	5,871	$626K
92557		<1%	10,684	$614K
84443	Thyroid stimulating hormone (TSH)	<1%	64,613	$606K
93325		<1%	6,843	$597K
J2506	Injection, pegfilgrastim, excludes biosimilar, 0.5 mg	<1%	592	$592K
92567		<1%	19,984	$586K
97165		<1%	7,824	$568K
G0108	Diabetes outpatient self-management training services, individual, per 30 minutes	<1%	8,403	$559K
76801		<1%	5,826	$556K
71250		<1%	7,735	$555K
J0185	Injection, aprepitant, 1 mg	<1%	2,985	$553K
31231		<1%	2,960	$550K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	33,625	$545K
93017		<1%	6,509	$541K
ATP08		<1%	76,734	$540K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	11,669	$540K
77336		<1%	8,332	$537K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	3,989	$526K
J0248	Injection, remdesivir, 1 mg	<1%	1,649	$506K
J2469	Injection, palonosetron hcl, 25 mcg	<1%	7,160	$500K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	48,470	$498K
17110		<1%	3,094	$496K
95816		<1%	2,200	$487K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	3,186	$487K
83036	Hemoglobin; glycosylated (A1C)	<1%	97,886	$480K
V5160	Dispensing fee, binaural	<1%	980	$461K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	66,048	$460K
12001		<1%	2,110	$453K
84484		<1%	67,838	$445K
76882		<1%	4,795	$441K
81220	CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants	<1%	1,005	$433K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	3,134	$413K
J1756	Injection, iron sucrose, 1 mg	<1%	7,345	$404K
J0178	Injection, aflibercept, 1 mg	<1%	462	$402K
58300		<1%	2,016	$400K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	21,441	$399K
76813		<1%	3,531	$392K
80053	Comprehensive metabolic panel	<1%	190,235	$388K
90686		<1%	35,913	$384K
J3490	Unclassified drugs	<1%	5,489	$382K
11104		<1%	863	$365K
J7323	Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose	<1%	1,924	$359K
87086	Culture, bacterial; quantitative colony count, urine	<1%	68,062	$356K
47562		<1%	131	$355K
12011		<1%	1,594	$350K
96411		<1%	1,759	$346K
19083		<1%	431	$344K
58100		<1%	1,612	$343K
10060		<1%	1,955	$343K
93970		<1%	1,873	$339K
86480		<1%	8,441	$337K
70491		<1%	2,473	$337K
D1208	Topical application of fluoride, excluding varnish	<1%	15,286	$336K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	140,859	$334K
A0433	Advanced life support, level 2 (als 2)	<1%	794	$331K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	76,285	$330K
88185		<1%	1,769	$330K
93271		<1%	4,707	$321K
93321		<1%	2,710	$319K
95819		<1%	1,168	$311K
29700		<1%	1,470	$310K
73564		<1%	21,123	$307K
11900		<1%	1,626	$306K
J1050	Injection, medroxyprogesterone acetate, 1 mg	<1%	6,795	$306K
80048	Basic metabolic panel (calcium, ionized)	<1%	196,136	$303K
83735		<1%	87,266	$302K
77300		<1%	2,205	$300K
81025		<1%	54,049	$299K
86850		<1%	46,927	$296K
87631		<1%	2,954	$290K
77062		<1%	3,795	$288K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	20,800	$287K
85027		<1%	73,677	$286K
96900		<1%	5,897	$282K
92012	Ophthalmological services: medical examination and evaluation, intermediate, established patient	<1%	3,677	$282K
93303	Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study	<1%	1,206	$281K
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	22,782	$277K
84702		<1%	21,977	$274K
76870		<1%	3,192	$272K
29405		<1%	1,498	$272K
95070		<1%	756	$271K
92004	Ophthalmological services: medical examination and evaluation, comprehensive, new patient	<1%	4,551	$270K
90651		<1%	4,428	$270K
87536		<1%	6,004	$267K
J1650	Injection, enoxaparin sodium, 10 mg	<1%	25,710	$267K
J0897	Injection, denosumab, 1 mg	<1%	567	$264K
Q0222	Injection, bebtelovimab, 175 mg	<1%	309	$263K
J1950	Injection, leuprolide acetate (for depot suspension), per 3.75 mg	<1%	215	$262K
87088		<1%	48,199	$261K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	12,135	$259K
49083		<1%	735	$257K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	26,074	$255K
D1351	Sealant - per tooth	<1%	22,475	$255K
82728		<1%	31,197	$254K
96416		<1%	1,713	$254K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	44,785	$253K
90715		<1%	13,194	$252K
Q5108	Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg	<1%	115	$251K
77065	Tomosynthesis, mammo	<1%	5,872	$251K
64615		<1%	1,001	$251K
77080		<1%	4,649	$249K
58558		<1%	216	$248K
73630		<1%	27,160	$247K
93880		<1%	3,056	$245K
J1453	Injection, fosaprepitant, 1 mg	<1%	624	$241K
96127		<1%	4,872	$240K
97161		<1%	4,815	$237K
86003		<1%	3,158	$229K
83690		<1%	49,317	$225K
J9310	Injection, rituximab, 100 mg	<1%	346	$224K
73610		<1%	21,187	$223K
95813		<1%	478	$222K
94060		<1%	3,146	$216K
77061		<1%	2,690	$215K
96409		<1%	1,434	$212K
58661		<1%	102	$210K
83880		<1%	12,969	$208K
86803		<1%	22,966	$207K
87480		<1%	13,320	$204K
87510		<1%	13,321	$204K
87660		<1%	13,299	$203K
G0105	Colorectal cancer screening; colonoscopy on individual at high risk	<1%	421	$202K
73030		<1%	19,158	$202K
ATP15		<1%	27,171	$202K
77072		<1%	1,797	$202K
94010		<1%	5,501	$201K
74178		<1%	1,350	$201K
10005		<1%	779	$199K
73130		<1%	21,968	$194K
70498		<1%	5,071	$193K
81513		<1%	1,847	$188K
58301		<1%	1,032	$184K
80050	General health panel	<1%	11,960	$184K
72100		<1%	14,364	$183K
92579		<1%	3,964	$183K
83605		<1%	25,507	$181K
84466		<1%	24,438	$179K
76820		<1%	4,160	$178K
11981		<1%	559	$176K
93296		<1%	6,214	$174K
82607		<1%	22,418	$173K
12002		<1%	840	$173K
71275	Computed tomographic angiography, chest, with contrast material	<1%	1,173	$172K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	69,722	$171K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	13,853	$167K
77334		<1%	1,423	$166K
93922		<1%	3,469	$166K
87522	Neg quan hep c or qual rna	<1%	5,980	$166K
29705		<1%	800	$164K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	76,872	$164K
77066	Tomosynthesis, mammo	<1%	5,514	$160K
81001		<1%	79,062	$160K
73110		<1%	17,315	$160K
85610		<1%	84,844	$158K
V5266	Battery for use in hearing device	<1%	1,860	$156K
69210		<1%	3,433	$156K
96368		<1%	2,730	$155K
70486		<1%	2,292	$154K
64721		<1%	195	$153K
17000		<1%	1,532	$150K
77295		<1%	347	$147K
76604		<1%	1,974	$147K
78451		<1%	456	$146K
82803		<1%	9,660	$144K
83970		<1%	8,849	$144K
M0222	Intravenous injection, bebtelovimab, includes injection and post administration monitoring	<1%	859	$143K
92134		<1%	16,738	$143K
81511		<1%	1,572	$143K
92585		<1%	462	$143K
88307		<1%	3,195	$142K
94070		<1%	826	$142K
87040		<1%	19,793	$141K
J2543	Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)	<1%	7,323	$140K
52310		<1%	251	$139K
36224		<1%	60	$139K
74230		<1%	1,096	$139K
D0120	Dental checkup, returning patient	<1%	4,739	$135K
86317		<1%	13,464	$134K
84439		<1%	23,798	$134K
97804		<1%	1,648	$133K
87340		<1%	18,081	$126K
93458		<1%	117	$125K
96375	Therapeutic injection; each additional sequential IV push	<1%	57,394	$124K
72125	Computed tomography, cervical spine; without contrast material	<1%	9,458	$123K
J3111	Injection, romosozumab-aqqg, 1 mg	<1%	285	$123K
92555		<1%	3,315	$122K
99385		<1%	1,581	$122K
86900		<1%	46,831	$121K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	50,772	$120K
92015	Determination of refractive state	<1%	9,921	$119K
J9217	Leuprolide acetate (for depot suspension), 7.5 mg	<1%	363	$119K
M0243	Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring	<1%	466	$118K
76942		<1%	2,807	$117K
90714		<1%	5,283	$115K
73502		<1%	11,199	$115K
88341		<1%	6,015	$114K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	6,200	$111K
J2704	Injection, propofol, 10 mg	<1%	65,540	$110K
82746		<1%	15,074	$110K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	874	$110K
87077		<1%	21,314	$107K
J1815	Injection, insulin, per 5 units	<1%	21,454	$106K
76857		<1%	1,381	$106K
76886		<1%	854	$106K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	4,098	$105K
84403		<1%	6,418	$105K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	49,135	$105K
86360		<1%	4,809	$104K
74018		<1%	5,416	$104K
88142		<1%	7,043	$103K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	39,226	$103K
17311		<1%	319	$103K
93351		<1%	1,579	$102K
83655		<1%	9,322	$102K
83540		<1%	27,130	$102K
81329		<1%	933	$102K
71271		<1%	2,622	$101K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	4,599	$101K
0001A		<1%	3,332	$100K
86140		<1%	32,229	$100K
G2066	Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results	<1%	2,473	$100K
88173		<1%	2,513	$99K
11100		<1%	414	$99K
88112		<1%	3,510	$99K
G0297	Low dose ct scan (ldct) for lung cancer screening	<1%	816	$99K
84703		<1%	17,358	$98K
87186		<1%	17,665	$98K
82784		<1%	11,824	$97K
82570		<1%	34,777	$95K
71045	Radiologic examination, chest; single view	<1%	28,712	$94K
76775		<1%	1,282	$93K
76937		<1%	3,266	$92K
82105		<1%	8,611	$92K
86901		<1%	46,685	$91K
0002A		<1%	2,942	$91K
72050		<1%	3,538	$90K
51700		<1%	455	$89K
94727		<1%	2,683	$89K
62321		<1%	165	$89K
73700		<1%	962	$88K
74019		<1%	6,440	$86K
92611		<1%	1,215	$86K
86762		<1%	6,915	$85K
81003		<1%	55,746	$84K
74174		<1%	1,211	$84K
36415	Collection of venous blood by venipuncture	<1%	483,825	$84K
86359		<1%	4,809	$84K
C9257	Injection, bevacizumab, 0.25 mg	<1%	5,399	$83K
87081		<1%	14,436	$83K
58340		<1%	137	$82K
J1644	Injection, heparin sodium, per 1000 units	<1%	14,777	$81K
87497		<1%	6,110	$81K
97162		<1%	2,158	$81K
94729		<1%	3,835	$80K
Q5107	Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg	<1%	150	$80K
90834	Psychotherapy session, about 45 minutes	<1%	914	$80K
75574		<1%	498	$79K
77002		<1%	1,339	$78K
62270		<1%	176	$77K
73140		<1%	7,989	$77K
86787		<1%	7,177	$77K
93226		<1%	2,010	$77K
ATP17		<1%	10,280	$76K
90677		<1%	1,846	$76K
80061	Lipid panel	<1%	56,929	$75K
93225		<1%	1,435	$75K
95911		<1%	1,222	$75K
V5264	Ear mold/insert, not disposable, any type	<1%	1,018	$75K
93926		<1%	541	$74K
84153		<1%	9,883	$73K
82670		<1%	3,859	$73K
87481		<1%	1,865	$73K
73080		<1%	7,135	$73K
64415		<1%	408	$73K
95117		<1%	3,356	$71K
87070		<1%	13,050	$71K
73590		<1%	8,984	$71K
M0247	Intravenous infusion, sotrovimab, includes infusion and post administration monitoring	<1%	301	$70K
72082		<1%	2,031	$69K
72110		<1%	2,583	$66K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	1,065	$66K
92595		<1%	1,204	$64K
87641		<1%	4,553	$64K
80074		<1%	2,156	$64K
43237		<1%	121	$64K
95912		<1%	910	$64K
86235		<1%	2,047	$63K
77387		<1%	4,018	$63K
84146		<1%	4,841	$63K
83001		<1%	5,029	$63K
43264		<1%	58	$63K
20550		<1%	432	$63K
J0885	Injection, epoetin alfa, (for non-esrd use), 1000 units	<1%	55	$62K
86592		<1%	18,700	$61K
92582		<1%	1,556	$61K
ATP03		<1%	21,643	$60K
86780		<1%	5,835	$60K
J1170	Injection, hydromorphone, up to 4 mg	<1%	13,290	$59K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	68,658	$59K
26055		<1%	114	$59K
83516		<1%	5,126	$58K
J2997	Injection, alteplase recombinant, 1 mg	<1%	732	$58K
29125		<1%	617	$58K
82043		<1%	21,962	$58K
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	<1%	514	$58K
92553		<1%	1,069	$56K
84402		<1%	3,169	$56K
88184		<1%	1,800	$56K
86704		<1%	7,750	$55K
80197		<1%	14,010	$55K
96401		<1%	492	$55K
77301		<1%	183	$55K
0124A		<1%	2,326	$54K
85730		<1%	14,707	$53K
90480		<1%	1,519	$53K
86038		<1%	7,387	$52K
74170		<1%	232	$52K
52332		<1%	141	$52K
C9803	Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	13,019	$52K
99386		<1%	709	$51K
J0574	Buprenorphine/naloxone, oral, greater than 6 mg, but less than or equal to 10 mg buprenorphine	<1%	2,075	$51K
90670		<1%	8,921	$50K
93270		<1%	1,103	$50K
85379		<1%	7,315	$50K
Q3014	Telehealth originating site facility fee	<1%	25,690	$50K
J0690	Injection, cefazolin sodium, 500 mg	<1%	19,301	$50K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	18,686	$50K
87902		<1%	435	$50K
ATP16		<1%	5,912	$48K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	21,410	$48K
ATP10		<1%	7,111	$48K
77290		<1%	216	$48K
77280		<1%	298	$47K
83002		<1%	3,596	$47K
73090		<1%	7,163	$47K
85652		<1%	29,133	$47K
99152		<1%	11,263	$46K
73562		<1%	6,572	$45K
29065		<1%	186	$45K
92133		<1%	5,124	$45K
87799		<1%	3,816	$44K
ATP09		<1%	6,150	$44K
81002		<1%	18,241	$44K
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	5,718	$42K
86618		<1%	4,068	$42K
86160		<1%	3,330	$42K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	3,716	$42K
76825		<1%	474	$41K
92083		<1%	4,087	$41K
97535	Self-care/home management training, each 15 minutes	<1%	951	$40K
82962		<1%	125,147	$40K
72070		<1%	2,936	$40K
V5014	Repair/modification of a hearing aid	<1%	744	$40K
47563		<1%	13	$40K
64635		<1%	63	$40K
97035		<1%	696	$40K
93923		<1%	702	$40K
95812		<1%	96	$40K
82652		<1%	1,666	$39K
73560		<1%	6,784	$39K
90846	Family psychotherapy without the patient present, 50 minutes	<1%	466	$39K
11056		<1%	446	$39K
20553		<1%	277	$39K
11721		<1%	3,647	$39K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	2,566	$39K
88342		<1%	9,292	$38K
95165	Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials	<1%	3,654	$38K
92652		<1%	676	$38K
J1439	Injection, ferric carboxymaltose, 1 mg	<1%	95	$38K
ATP11		<1%	6,228	$38K
73552		<1%	5,745	$38K
66982		<1%	63	$37K
87517		<1%	1,589	$37K
72040		<1%	3,287	$36K
83020		<1%	3,472	$36K
90739		<1%	1,735	$36K
86833		<1%	1,189	$36K
A9270	Non-covered item or service	<1%	30,154	$35K
0003A		<1%	974	$35K
86923		<1%	3,162	$35K
92250		<1%	4,299	$35K
88360		<1%	1,488	$34K
90691		<1%	1,770	$34K
86832		<1%	804	$33K
36902		<1%	12	$33K
11982		<1%	202	$33K
90472	Immunization administration, each additional vaccine (list separately)	<1%	27,081	$33K
82785		<1%	2,966	$33K
P9016	Red blood cells, leukocytes reduced, each unit	<1%	2,606	$33K
90656		<1%	1,756	$33K
86800		<1%	3,447	$33K
57454		<1%	108	$32K
87205		<1%	11,505	$32K
C8929	Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography	<1%	365	$32K
0071A		<1%	706	$32K
85018		<1%	17,957	$31K
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	<1%	2,161	$31K
82951		<1%	2,608	$31K
J9263	Injection, oxaliplatin, 0.5 mg	<1%	151	$30K
72170		<1%	4,189	$30K
87075		<1%	5,734	$30K
85045		<1%	9,803	$30K
92591		<1%	950	$29K
90717		<1%	669	$29K
84480		<1%	3,063	$29K
ATP07		<1%	4,399	$29K
74221		<1%	265	$29K
99153	Mod sedat endo service >5yrs	<1%	8,950	$29K
86376		<1%	2,994	$29K
42830		<1%	15	$29K
90732		<1%	2,405	$28K
82627		<1%	1,728	$28K
76519		<1%	622	$28K
57455		<1%	102	$27K
92594		<1%	1,216	$27K
64450		<1%	146	$27K
0053A		<1%	868	$27K
84156		<1%	11,662	$27K
C1769	Guide wire	<1%	8,353	$27K
J3475	Injection, magnesium sulfate, per 500 mg	<1%	10,351	$26K
J0689	Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg	<1%	4,755	$26K
84165		<1%	5,760	$26K
83520		<1%	2,151	$26K
76827		<1%	516	$26K
0072A		<1%	564	$26K
90746		<1%	1,211	$25K
10061		<1%	164	$25K
20552		<1%	148	$25K
G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	<1%	1,725	$25K
82378		<1%	2,743	$25K
81508		<1%	961	$25K
86708		<1%	3,409	$25K
J0171	Injection, adrenalin, epinephrine, 0.1 mg	<1%	4,897	$25K
36600		<1%	1,835	$25K
90847	Family psychotherapy with the patient present, 50 minutes	<1%	290	$25K
80076		<1%	39,033	$24K
99201		<1%	268	$24K
95913		<1%	504	$24K
72081		<1%	1,296	$24K
99383		<1%	398	$24K
72131		<1%	734	$24K
76885		<1%	101	$24K
69200		<1%	313	$23K
J1720	Injection, hydrocortisone sodium succinate, up to 100 mg	<1%	3,485	$23K
J1071	Injection, testosterone cypionate, 1 mg	<1%	1,511	$23K
90832	Psychotherapy session, about 30 minutes	<1%	541	$23K
86304		<1%	2,349	$23K
41899	Unlisted procedure, dentoalveolar structures	<1%	26	$23K
Q0162	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	18,697	$23K
99381		<1%	288	$23K
96910		<1%	598	$22K
71101		<1%	1,198	$22K
84134		<1%	3,593	$22K
74246		<1%	135	$22K
86200		<1%	3,028	$22K
86147		<1%	545	$22K
86665		<1%	1,649	$22K
92285		<1%	1,412	$21K
73523		<1%	1,234	$21K
J3489	Injection, zoledronic acid, 1 mg	<1%	1,328	$21K
82677		<1%	1,071	$21K
83498		<1%	937	$21K
V5267	Hearing aid or assistive listening device/supplies/accessories, not otherwise specified	<1%	840	$21K
93304		<1%	55	$20K
77338		<1%	194	$20K
73060		<1%	3,759	$20K
83721		<1%	4,183	$20K
90632		<1%	1,190	$20K
90662		<1%	2,382	$20K
77001		<1%	358	$19K
64494		<1%	1,951	$19K
84681		<1%	1,595	$19K
99397		<1%	604	$19K
70360		<1%	1,059	$19K
86225		<1%	2,912	$19K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	958	$19K
G0008	Administration of influenza virus vaccine	<1%	9,027	$19K
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	8,143	$19K
73000		<1%	1,724	$19K
ATP02		<1%	4,625	$18K
ATP18		<1%	2,724	$18K
ATP04		<1%	3,214	$18K
J2790	Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.)	<1%	121	$18K
95910		<1%	242	$18K
64490		<1%	25	$18K
43762		<1%	98	$18K
10022		<1%	127	$18K
73070		<1%	2,812	$18K
12032		<1%	269	$17K
D1110	Prophylaxis - adult	<1%	824	$17K
80177		<1%	2,251	$17K
82533		<1%	1,916	$17K
97166		<1%	293	$17K
84163		<1%	1,234	$17K
91200		<1%	200	$17K
72072		<1%	1,129	$17K
99406		<1%	1,464	$17K
93280		<1%	850	$17K
90734		<1%	4,018	$17K
93298		<1%	766	$17K
85014		<1%	9,376	$16K
95004	Percutaneous tests with allergenic extracts, immediate type reaction	<1%	306	$16K
93299		<1%	412	$16K
J7050	Infusion, normal saline solution, 250 cc	<1%	35,454	$16K
86336		<1%	1,093	$16K
51798		<1%	10,411	$16K
51728		<1%	78	$16K
80164		<1%	2,650	$16K
86077		<1%	576	$16K
0012A		<1%	1,033	$16K
87449		<1%	2,220	$16K
84450		<1%	12,840	$16K
87338		<1%	1,566	$15K
84481		<1%	1,325	$15K
82274		<1%	1,553	$15K
80069		<1%	12,952	$15K
20605		<1%	89	$15K
91322		<1%	442	$15K
86870		<1%	807	$15K
97760		<1%	321	$15K
86920		<1%	1,362	$14K
0011A		<1%	1,056	$14K
82950		<1%	3,491	$14K
0111A		<1%	327	$14K
86334		<1%	1,723	$14K
83883		<1%	1,312	$14K
86431		<1%	3,981	$14K
86146		<1%	422	$13K
84305		<1%	937	$13K
82150		<1%	3,259	$13K
82330		<1%	1,931	$13K
73521		<1%	694	$13K
38222		<1%	45	$13K
74220		<1%	203	$13K
92504		<1%	1,340	$12K
25605		<1%	25	$12K
64644		<1%	146	$12K
V5275	Ear impression, each	<1%	954	$12K
83013		<1%	236	$12K
93978		<1%	150	$12K
95250		<1%	386	$12K
84100		<1%	35,959	$12K
0052A		<1%	305	$12K
87147		<1%	2,632	$12K
99218		<1%	1,662	$12K
97116		<1%	480	$11K
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	2,166	$11K
88304		<1%	9,279	$11K
78264		<1%	44	$11K
J9355	Injection, trastuzumab, excludes biosimilar, 10 mg	<1%	45	$11K
70480		<1%	199	$11K
M0220	Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), includes injection and post administration monitoring	<1%	199	$11K
82565		<1%	18,594	$11K
82088		<1%	489	$11K
0112A		<1%	233	$11K
64405		<1%	37	$11K
67840		<1%	14	$11K
19081		<1%	13	$11K
92626		<1%	147	$11K
87427		<1%	1,415	$11K
89051		<1%	3,099	$10K
0031A		<1%	379	$10K
J0461	Injection, atropine sulfate, 0.01 mg	<1%	571	$10K
64495		<1%	763	$10K
J2785	Injection, regadenoson, 0.1 mg	<1%	3,391	$10K
86301		<1%	1,066	$10K
J3370	Injection, vancomycin hcl, 500 mg	<1%	4,473	$10K
36901		<1%	12	$10K
82550		<1%	10,216	$10K
11730		<1%	148	$10K
91010		<1%	13	$10K
86765		<1%	1,003	$10K
87206		<1%	2,486	$10K
86735		<1%	981	$9K
83615		<1%	16,126	$9K
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	4,543	$9K
93320		<1%	1,396	$9K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	305	$9K
84445		<1%	307	$9K
83521		<1%	1,737	$9K
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	<1%	1,661	$9K
96376		<1%	11,076	$9K
74328		<1%	287	$9K
0051A		<1%	224	$9K
99384		<1%	241	$9K
87045		<1%	1,441	$9K
87102		<1%	1,715	$9K
94664		<1%	4,537	$9K
80179		<1%	2,268	$9K
J0295	Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm	<1%	2,150	$9K
92002		<1%	104	$8K
51705		<1%	38	$8K
ATP13		<1%	1,197	$8K
74160		<1%	101	$8K
99205	Prolong outpt/office vis	<1%	72	$8K
86258		<1%	1,348	$8K
90716		<1%	2,164	$8K
88302		<1%	1,662	$8K
55700		<1%	16	$8K
90633		<1%	4,929	$8K
76831		<1%	59	$8K
82140		<1%	959	$8K
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	<1%	203	$8K
84270		<1%	571	$8K
92610		<1%	66	$8K
90999	Dialysis (unlisted procedure)	<1%	156	$7K
86021		<1%	1,151	$7K
J2060	Injection, lorazepam, 2 mg	<1%	8,046	$7K
83993		<1%	617	$7K
83921		<1%	774	$7K
51600		<1%	26	$7K
84244		<1%	559	$7K
J1030	Injection, methylprednisolone acetate, 40 mg	<1%	9,524	$7K
82610		<1%	666	$7K
36593		<1%	105	$7K
82365		<1%	899	$7K
82390		<1%	934	$7K
96523		<1%	449	$7K
87521	Neg quan hep c or qual rna	<1%	335	$7K
86580		<1%	1,218	$7K
36561		<1%	13	$7K
36589		<1%	25	$7K
27096		<1%	13	$7K
85041		<1%	2,627	$6K
94726		<1%	137	$6K
86664		<1%	551	$6K
11103		<1%	210	$6K
J1726	Injection, hydroxyprogesterone caproate, (makena), 10 mg	<1%	80	$6K
51702		<1%	2,743	$6K
95909		<1%	92	$6K
94761		<1%	6,367	$6K
ATP05		<1%	988	$6K
99402		<1%	681	$6K
81229		<1%	221	$6K
J7030	Infusion, normal saline solution , 1000 cc	<1%	19,314	$6K
J7120	Ringers lactate infusion, up to 1000 cc	<1%	15,808	$6K
83021		<1%	408	$6K
86039		<1%	860	$6K
0054A		<1%	307	$6K
84432		<1%	783	$6K
86255		<1%	901	$6K
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	10,558	$6K
88300		<1%	2,060	$6K
96112		<1%	252	$6K
74022		<1%	805	$6K
86341		<1%	655	$5K
80175		<1%	910	$5K
84300		<1%	1,665	$5K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	281	$5K
84550		<1%	12,490	$5K
83525		<1%	544	$5K
84132		<1%	4,712	$5K
77091		<1%	816	$5K
90707		<1%	2,488	$5K
84460		<1%	14,270	$5K
J0640	Injection, leucovorin calcium, per 50 mg	<1%	2,048	$5K
0073A		<1%	108	$5K
99382		<1%	126	$5K
J1750	Injection, iron dextran, 50 mg	<1%	182	$5K
51784		<1%	24	$5K
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	9,802	$5K
87116		<1%	788	$5K
86008		<1%	36	$5K
J1630	Injection, haloperidol, up to 5 mg	<1%	2,623	$5K
92588		<1%	27	$5K
90685		<1%	1,065	$5K
80183		<1%	590	$4K
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	<1%	5,235	$4K
88720		<1%	986	$4K
17312		<1%	39	$4K
87046		<1%	616	$4K
86705		<1%	511	$4K
43259		<1%	16	$4K
88237		<1%	88	$4K
82103		<1%	475	$4K
J0702	Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg	<1%	78	$4K
82040		<1%	6,600	$4K
92511		<1%	14	$4K
85347		<1%	1,431	$4K
29580		<1%	28	$4K
52005		<1%	26	$4K
29823		<1%	12	$4K
0064A		<1%	247	$4K
90648		<1%	1,291	$4K
82024		<1%	191	$4K
87324		<1%	626	$4K
ATP23		<1%	377	$4K
84425		<1%	332	$4K
80047		<1%	4,015	$4K
96417		<1%	4,519	$4K
86696		<1%	248	$4K
87015		<1%	997	$4K
83010		<1%	460	$4K
82340		<1%	903	$4K
51741		<1%	151	$4K
73660		<1%	229	$3K
95885		<1%	39	$3K
J1040	Injection, methylprednisolone acetate, 80 mg	<1%	5,196	$3K
87209		<1%	283	$3K
J0780	Injection, prochlorperazine, up to 10 mg	<1%	1,149	$3K
90653		<1%	245	$3K
80178		<1%	881	$3K
P9040	Red blood cells, leukocytes reduced, irradiated, each unit	<1%	606	$3K
82077		<1%	3,367	$3K
J2272	Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg	<1%	2,194	$3K
82397		<1%	339	$3K
83519		<1%	329	$3K
J2920	Injection, methylprednisolone sodium succinate, up to 40 mg	<1%	975	$3K
90696		<1%	1,612	$3K
0154A		<1%	90	$3K
82947		<1%	3,798	$3K
92700		<1%	27	$3K
82310		<1%	5,237	$3K
84520		<1%	7,429	$3K
90673		<1%	115	$3K
20600		<1%	13	$3K
17003		<1%	317	$3K
72220		<1%	222	$3K
94760		<1%	3,033	$3K
J0561	Injection, penicillin g benzathine, 100,000 units	<1%	18	$3K
92604		<1%	96	$3K
84144		<1%	208	$3K
80165		<1%	434	$3K
88264		<1%	41	$3K
83550		<1%	710	$2K
86695		<1%	244	$2K
G0145	Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision	<1%	1,889	$2K
36591		<1%	2,577	$2K
86644		<1%	245	$2K
86364		<1%	2,981	$2K
84155		<1%	5,342	$2K
87210		<1%	569	$2K
73565		<1%	742	$2K
82172		<1%	205	$2K
90473		<1%	4,560	$2K
86308		<1%	527	$2K
G0475	Hiv antigen/antibody, combination assay, screening	<1%	2,098	$2K
J0572	Buprenorphine/naloxone, oral, less than or equal to 3 mg buprenorphine	<1%	55	$2K
90791	Psychiatric diagnostic evaluation	<1%	89	$2K
H0035	Mental health partial hospitalization, treatment, less than 24 hours	<1%	14	$2K
J8499	Prescription drug, oral, non chemotherapeutic, nos	<1%	2,826	$2K
85576		<1%	132	$2K
88312		<1%	2,048	$2K
84157		<1%	907	$2K
78306		<1%	19	$2K
82945		<1%	832	$2K
82248		<1%	4,082	$2K
70487		<1%	26	$2K
92540		<1%	54	$2K
0164A		<1%	42	$2K
69209		<1%	12	$2K
A9505	Thallium tl-201 thallous chloride, diagnostic, per millicurie	<1%	1,210	$2K
80143		<1%	2,021	$2K
88313		<1%	801	$2K
83718		<1%	301	$2K
J9045	Injection, carboplatin, 50 mg	<1%	1,368	$2K
80156		<1%	339	$2K
87177		<1%	282	$2K
86141		<1%	278	$2K
J2310	Injection, naloxone hydrochloride, per 1 mg	<1%	53	$2K
G0009	Administration of pneumococcal vaccine	<1%	2,468	$2K
90620		<1%	70	$2K
76706		<1%	43	$2K
87650		<1%	155	$2K
82247		<1%	1,616	$2K
D1120	Dental cleaning, child	<1%	30	$1K
92593		<1%	67	$1K
V5020	Conformity evaluation	<1%	24	$1K
92551		<1%	12	$1K
J1790	Injection, droperidol, up to 5 mg	<1%	2,222	$1K
80203		<1%	205	$1K
92556		<1%	26	$1K
85613		<1%	231	$1K
72190		<1%	224	$1K
J0694	Injection, cefoxitin sodium, 1 gm	<1%	128	$1K
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	15,862	$1K
82104		<1%	153	$1K
83935		<1%	369	$1K
95874		<1%	541	$1K
86381		<1%	357	$1K
87640		<1%	661	$1K
36592		<1%	2,086	$1K
90678		<1%	47	$1K
89060		<1%	348	$1K
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	<1%	6,640	$1K
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	10,379	$1K
J3360	Injection, diazepam, up to 5 mg	<1%	680	$1K
88262		<1%	12	$1K
83835		<1%	117	$1K
82977		<1%	2,259	$1K
87625		<1%	153	$1K
93976		<1%	12	$1K
77073		<1%	45	$1K
72080		<1%	43	$1K
84166		<1%	158	$1K
J0456	Injection, azithromycin, 500 mg	<1%	228	$1K
88230		<1%	12	$1K
73200		<1%	25	$1K
C1887	Catheter, guiding (may include infusion/perfusion capability)	<1%	1,577	$1K
88311		<1%	1,386	$992.05
76098		<1%	13	$973.30
88172		<1%	54	$950.16
76872		<1%	16	$936.46
84590		<1%	120	$935.06
51701		<1%	1,905	$907.62
64643		<1%	14	$900.62
82952		<1%	281	$896.82
86593		<1%	303	$895.94
72202		<1%	93	$847.04
82731		<1%	14	$822.50
86617		<1%	182	$816.00
92537		<1%	14	$815.68
82465		<1%	906	$779.34
J1580	Injection, garamycin, gentamicin, up to 80 mg	<1%	241	$771.17
12051		<1%	13	$765.21
98926		<1%	15	$757.35
75625		<1%	12	$750.57
81206		<1%	13	$747.80
86812		<1%	40	$746.26
86015		<1%	529	$668.41
90744		<1%	3,151	$649.10
71100		<1%	26	$630.64
96111		<1%	467	$629.87
86922		<1%	54	$624.96
80185		<1%	128	$624.78
93312		<1%	12	$612.60
87255		<1%	27	$583.11
84446		<1%	65	$582.61
J3411	Injection, thiamine hcl, 100 mg	<1%	164	$564.28
V5011	Fitting/orientation/checking of hearing aid	<1%	25	$562.16
A9500	Technetium tc-99m sestamibi, diagnostic, per study dose	<1%	2,593	$557.57
77081		<1%	12	$540.77
73100		<1%	104	$531.85
93229		<1%	12	$522.00
82507		<1%	26	$507.40
90636		<1%	74	$504.53
95249		<1%	12	$487.85
87329		<1%	53	$474.33
70250		<1%	41	$472.98
J9267	Injection, paclitaxel, 1 mg	<1%	1,317	$471.35
C1760	Closure device, vascular (implantable/insertable)	<1%	692	$455.54
86355		<1%	43	$451.50
82010		<1%	75	$428.14
64484		<1%	158	$411.30
S0119	Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code)	<1%	941	$411.01
C2617	Stent, non-coronary, temporary, without delivery system	<1%	1,758	$407.34
82375		<1%	52	$406.98
86357		<1%	27	$404.26
82553		<1%	53	$377.57
90661		<1%	28	$362.00
A4648	Tissue marker, implantable, any type, each	<1%	1,072	$347.94
83930		<1%	75	$347.74
C1726	Catheter, balloon dilatation, non-vascular	<1%	372	$345.56
80202		<1%	71	$340.88
82166		<1%	14	$340.60
87220		<1%	121	$338.83
90682		<1%	219	$337.79
J0692	Injection, cefepime hydrochloride, 500 mg	<1%	246	$336.96
98927		<1%	14	$328.01
75710		<1%	12	$321.67
80195		<1%	53	$313.25
82272		<1%	185	$312.99
82157		<1%	12	$309.84
92517		<1%	12	$298.21
J2795	Injection, ropivacaine hydrochloride, 1 mg	<1%	1,820	$297.28
76376		<1%	3,282	$296.61
V2632	Posterior chamber intraocular lens	<1%	1,664	$286.97
96377		<1%	803	$274.97
P9047	Infusion, albumin (human), 25%, 50 ml	<1%	53	$267.98
76514		<1%	14	$262.36
82787		<1%	15	$254.52
82085		<1%	41	$254.18
C1725	Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability)	<1%	919	$254.02
86769		<1%	14	$252.78
ATP06		<1%	44	$250.48
87593		<1%	13	$247.60
83945		<1%	27	$246.54
92136		<1%	14	$241.20
82164		<1%	26	$234.92
80299		<1%	27	$222.77
93282		<1%	14	$208.25
80158		<1%	23	$204.82
A4217	Sterile water/saline, 500 ml	<1%	829	$201.51
82232		<1%	28	$199.97
36416		<1%	4,935	$196.80
84295		<1%	1,597	$185.41
J7510	Prednisolone oral, per 5 mg	<1%	193	$182.40
84206		<1%	12	$177.48
J1010	Injection, methylprednisolone acetate, 1 mg	<1%	1,073	$172.46
80184		<1%	41	$165.34
85384		<1%	24	$163.20
73650		<1%	27	$157.66
86777		<1%	13	$157.56
84133		<1%	53	$157.20
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	542	$155.11
J2471	Injection, pantoprazole (hikma), not therapeutically equivalent to j2470, 40 mg	<1%	125	$155.11
83090		<1%	12	$153.90
85660		<1%	48	$140.94
84630		<1%	13	$130.65
73010		<1%	15	$128.71
J0670	Injection, mepivacaine hydrochloride, per 10 ml	<1%	269	$128.36
J1956	Injection, levofloxacin, 250 mg	<1%	226	$128.36
90713		<1%	87	$125.08
83986		<1%	57	$120.00
87807		<1%	13	$118.10
86709		<1%	14	$116.20
J2370	Injection, phenylephrine hcl, up to 1 ml	<1%	1,654	$116.01
J9190	Injection, fluorouracil, 500 mg	<1%	2,746	$109.08
84105		<1%	27	$99.12
84075		<1%	753	$97.80
99195		<1%	29	$86.80
84392		<1%	26	$86.60
84560		<1%	26	$86.60
90474		<1%	689	$82.39
90688		<1%	40	$79.40
Q0163	Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen	<1%	6,374	$78.96
92025		<1%	46	$78.58
86880		<1%	27	$76.00
77417		<1%	47	$75.61
90619		<1%	112	$68.89
J2550	Injection, promethazine hcl, up to 50 mg	<1%	41	$54.04
84436		<1%	16	$49.56
91305		<1%	1,294	$47.76
C8930	Transthoracic echocardiography, with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report; including performance of continuous electrocardiographic monitoring, with physician supervision	<1%	146	$39.20
89055		<1%	13	$35.20
J2359	Injection, olanzapine, 0.5 mg	<1%	194	$27.94
90710		<1%	1,747	$23.88
81596		<1%	567	$20.00
84478		<1%	178	$15.54
73600		<1%	33	$15.11
C9399	Unclassified drugs or biologicals	<1%	820	$13.65
J3480	Injection, potassium chloride, per 2 meq	<1%	2,893	$6.26
G0101	Cervical or vaginal cancer screening; pelvic and clinical breast examination	<1%	128	$5.76
90700		<1%	165	$3.37
P9612	Catheterization for collection of specimen, single patient, all places of service	<1%	467	$3.15
Q0164	Prochlorperazine maleate, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	2,050	$2.58
81005		<1%	15	$2.24
G0010	Administration of hepatitis b vaccine	<1%	454	$1.61
G8978	Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	820	$0.01
G8979	Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	824	$0.01
Q9950	Injection, sulfur hexafluoride lipid microspheres, per ml	0%	892	$0.00
C1776	Joint device (implantable)	0%	57	$0.00
93356		0%	750	$0.00
L3913	Hand finger orthosis, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment	0%	329	$0.00
J7070	Infusion, d5w, 1000 cc	0%	1,784	$0.00
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	0%	168	$0.00
81479	Unlisted molecular pathology procedure	0%	316	$0.00
A9541	Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries	0%	235	$0.00
S0164	Injection, pantoprazole sodium, 40 mg	0%	3,034	$0.00
C1758	Catheter, ureteral	0%	90	$0.00
81336		0%	28	$0.00
G0500	Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate)	0%	1,075	$0.00
J3473	Injection, hyaluronidase, recombinant, 1 usp unit	0%	131	$0.00
G8989	Self care functional limitation, discharge status, at discharge from therapy or to end reporting	0%	125	$0.00
G0390	Trauma response team associated with hospital critical care service	0%	28	$0.00
G8985	Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	84	$0.00
Q9956	Injection, octafluoropropane microspheres, per ml	0%	182	$0.00
99188		0%	97	$0.00
64491		0%	25	$0.00
91300		0%	5,371	$0.00
L3908	Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf	0%	57	$0.00
91312		0%	2,116	$0.00
J1953	Injection, levetiracetam, 10 mg	0%	501	$0.00
J0736	Injection, clindamycin phosphate, 300 mg	0%	82	$0.00
G8997	Swallowing functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	26	$0.00
Q9958	High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml	0%	55	$0.00
80361		0%	99	$0.00
G8996	Swallowing functional limitation, current status at therapy episode outset and at reporting intervals	0%	26	$0.00
11101		0%	31	$0.00
J1245	Injection, dipyridamole, per 10 mg	0%	100	$0.00
J2720	Injection, protamine sulfate, per 10 mg	0%	15	$0.00
80356		0%	32	$0.00
G8984	Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals	0%	47	$0.00
90687		0%	19	$0.00
C9113	Injection, pantoprazole sodium, per vial	0%	252	$0.00
74300		0%	13	$0.00
J1171	Injection, hydromorphone, 0.1 mg	0%	156	$0.00
87469		0%	156	$0.00
99157		0%	28	$0.00
91321		0%	18	$0.00
C1729	Catheter, drainage	0%	181	$0.00
91311		0%	580	$0.00
64636		0%	38	$0.00
86036		0%	23	$0.00
C1751	Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis)	0%	70	$0.00
J0744	Injection, ciprofloxacin for intravenous infusion, 200 mg	0%	16	$0.00
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	0%	23	$0.00
81450		0%	16	$0.00
L8613	Ossicula implant	0%	26	$0.00
C1874	Stent, coated/covered, with delivery system	0%	42	$0.00
99411		0%	28	$0.00
J9201	Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg	0%	37	$0.00
0042T		0%	15	$0.00
90698		0%	5,605	$0.00
90680		0%	5,122	$0.00
87493		0%	341	$0.00
90723		0%	593	$0.00
A9503	Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries	0%	100	$0.00
J1940	Injection, furosemide, up to 20 mg	0%	2,796	$0.00
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	0%	3,753	$0.00
C9290	Injection, bupivacaine liposome, 1 mg	0%	583	$0.00
G8987	Self care functional limitation, current status, at therapy episode outset and at reporting intervals	0%	303	$0.00
91303		0%	228	$0.00
96040		0%	1,290	$0.00
C2627	Catheter, suprapubic/cystoscopic	0%	290	$0.00
J1250	Injection, dobutamine hydrochloride, per 250 mg	0%	290	$0.00
G0328	Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous	0%	405	$0.00
C1781	Mesh (implantable)	0%	476	$0.00
L3906	Wrist hand orthosis, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment	0%	325	$0.00
G8980	Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting	0%	480	$0.00
87468		0%	132	$0.00
J8540	Dexamethasone, oral, 0.25 mg	0%	1,081	$0.00
91307		0%	1,426	$0.00
89322		0%	109	$0.00
91306		0%	68	$0.00
87478		0%	114	$0.00
91301		0%	1,231	$0.00
99156		0%	41	$0.00
90697		0%	645	$0.00
J3535	Drug administered through a metered dose inhaler	0%	18	$0.00
G0268	Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing	0%	114	$0.00
C1889	Implantable/insertable device, not otherwise classified	0%	578	$0.00
L3933	Finger orthosis, without joints, may include soft interface, custom fabricated, includes fitting and adjustment	0%	67	$0.00
J8501	Aprepitant, oral, 5 mg	0%	27	$0.00
J0360	Injection, hydralazine hcl, up to 20 mg	0%	113	$0.00
G8988	Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	346	$0.00
80051		0%	18	$0.00
Q9965	Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml	0%	13	$0.00
88309		0%	13	$0.00
51797		0%	43	$0.00
82435		0%	61	$0.00
94644		0%	119	$0.00
87484		0%	131	$0.00
L3808	Wrist hand finger orthosis, rigid without joints, may include soft interface material; straps, custom fabricated, includes fitting and adjustment	0%	32	$0.00
J7060	5% dextrose/water (500 ml = 1 unit)	0%	35	$0.00
91315		0%	45	$0.00
94660		0%	18	$0.00
J0280	Injection, aminophyllin, up to 250 mg	0%	41	$0.00
L3927	Finger orthosis, proximal interphalangeal (pip)/distal interphalangeal (dip), without joint/spring, extension/flexion (e.g., static or ring type), may include soft interface material, prefabricated, off-the-shelf	0%	24	$0.00
95012		0%	14	$0.00
49465		0%	17	$0.00
0361U		0%	26	$0.00
72052		0%	15	$0.00
64492		0%	12	$0.00
G8998	Swallowing functional limitation, discharge status, at discharge from therapy or to end reporting	0%	26	$0.00
J2003	Injection, lidocaine hydrochloride, 1 mg	0%	20	$0.00
C1730	Catheter, electrophysiology, diagnostic, other than 3d mapping (19 or fewer electrodes)	0%	26	$0.00
99292		0%	16	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMELGAR, SERGIO (EVP/CFO)

Same official

Other billing entities under MELGAR, SERGIO

Full network →

Provider	Location	Paid
Umass Memorial Medical Center, INC.	Worcester, MA	$56K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.